Drug-induced liver injury in cancer patients

QR Code

Drug-induced liver injury in cancer patients

This review includes information about epidemiological data, development feature, phenotypes, principles of classification, diagnosis, and prognosis for drug-induced liver injury (DILI). Actual clinical recommendations regarding management of the DILI arising in the chemotherapy of cancer discussed....

Full description

Saved in:

Bibliographic Details
Main Authors:	V. T. Ivashkin, K. L. Raikhelson, L. K. Palgova, M. V. Maevskaya, O. A. Gerasimova, E. A. Kondrashina, N. V. Marchenko, A. Yu. Baranovsky
Format:	Article
Language:	Russian
Published:	ABV-press 2020-10-01
Series:	Онкогематология
Subjects:	drug-induced liver injury hepatotoxicity cancer chemotherapy checkpoint inhibitor n-acetylcysteine glucocorticosteroids s-аdenosylmethionine bicyclol essential phospholipid
Online Access:	https://oncohematology.abvpress.ru/ongm/article/view/434
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Pharmacological correction of hepatotoxicity induced by anti-tuberculosis drugs
by: D. S. Sukhanov, et al.
Published: (2023-04-01)

Drug-Induced Liver Injuries (Clinical Guidelines for Physicians)
by: Vladimir T. Ivashkin, et al.
Published: (2019-03-01)

Efficacy of Heptral® in the treatment of hepatic toxicity induced by cytostatic chemotherapy
by: A. V. Snegovoy, et al.
Published: (2014-08-01)

Essential Phospholipids in the Treatment of the Metabolic Syndrome
by: E. N. Veselova, et al.
Published: (2012-03-01)

The use of bicyclol in the treatment of severe liver fibrosis: experimental rationale
by: K. V. Zhdanov, et al.
Published: (2021-01-01)

Polymorphism of genes and drug-induced liver injury
by: P. Ye. Tkachenko, et al.
Published: (2013-09-01)

A clinical case of immune-mediated pneumonitis after nivolumab in a patient with Burkitt lymphoma
by: K. I. Utesheva, et al.
Published: (2023-03-01)

Induced sputum cytology and nitric oxide in exhaled breath condensatein bronchial asthma patients
by: L. I. Volkova, et al.
Published: (2007-12-01)

EXPERIENCE IN THE USE OF ACETYLCYSTEINE IN THE TREATMENT OF RESPIRATORY INFECTIONS IN YOUNG CHILDREN
by: I. V. Davydova, et al.
Published: (2012-04-01)

The development of liposomal medicine technology in a form of solution for injection
by: G. I. Borshchevskіy
Published: (2015-12-01)

N-acetylcysteine in the Prevention of Contrast-induced Acute Kidney Injury: a Systematic Review and Meta-analysis of Randomized Controlled Clinical Trials
by: E. M. Mezhonov, et al.
Published: (2022-09-01)

Interchangeability of Essential Phospholipid Products
by: N. D. Bunyatyan, et al.
Published: (2019-12-01)

Comprehensive treatment of patients with type 2 diabetes, complicated by diabetic kidney disease, with concomitant non-alcoholic steatohepatitis
by: Z.Ya. Kotsiubiichuk, et al.
Published: (2025-04-01)

The dynamic of psycho-emotional condition in patients with chronic HCV infection (F1-F3) treated with bicyclol
by: K. V. Kozlov, et al.
Published: (2025-03-01)

Efficacy and Safety of Bicyclol Treatment for Non-Alcoholic Fatty Liver Disease: Results of a Cohort Study
by: I. Yu. Pirogova, et al.
Published: (2018-09-01)

Chemoimmunomodulation in triple negative breast cancer: a key to maximizing anti-PD-1 chemoimmunotherapeutic efficacy
by: Mohammed O. Gbadamosi, et al.
Published: (2025-12-01)

New treatment options for bladder cancer patients: based on ASCO 2022 materials and beyond
by: I. V. Zyatchin, et al.
Published: (2022-10-01)

PHARMACOEPIDEMIOLOGICAL EVALUATION OF HEPATOTROPIC THERAPY IN REAL CLINICAL PRACTICE
by: D. V. Blinov, et al.
Published: (2015-06-01)

GLUCOSE EXCHANGE DISORDERS IN PATIENTS TAKING GLUCOCORTICOSTEROIDS: FEATURES OF CLINICAL MANIFESTATIONS AND CORRECTION
by: Al’bert Yu. Selimov, et al.
Published: (2019-03-01)

CLIPPERS. Three clinical cases and review
by: L. N. Prakhova, et al.
Published: (2020-01-01)

A Delayed Presentation of Immune Checkpoint Inhibitor Colitis
by: Alicia Nahhas, et al.
Published: (2025-06-01)

Important aspects of carbohydrate metabolism disorders development in hematology/oncology patients during therapy with glucocorticosteroids: a review of the literature
by: N. T. Vatutin, et al.
Published: (2024-04-01)

Resistance to immune checkpoint inhibitors in the treatment of metastatic renal cancer
by: A. A. Izmailov, et al.
Published: (2023-09-01)

Immune checkpoint inhibitor myocarditis: a systematic case study
by: E. A. Kushnareva, et al.
Published: (2020-12-01)

Second primary malignancies of cancer patients: treatment-related carcinogenesis
by: G. A. Belitskiy, et al.
Published: (2016-09-01)

Immune Checkpoint Inhibitors in Urothelial Carcinoma (Literature Review)
by: K. V. Menshikov, et al.
Published: (2022-10-01)

Essential phospholipids: old physical substances – new production technology
by: Yu. P. Uspensky
Published: (2009-10-01)

Modification of antidote therapy for poisoning due to massive admission of paracetamol
by: A. Yu. Simonova, et al.
Published: (2022-12-01)

Hepatotoxicity Associated with Adalimumab in Hidradenitis Suppurativa: A Report of Two Cases of Drug-Induced Liver Injury
by: Cristian Fernando Caballero-Linares, et al.
Published: (2025-07-01)

Idiosyncratic Drug-Induced Liver Injury: From Pathogenesis to Risk Reduction
by: I. A. Mazerkina
Published: (2023-06-01)

получавших лечение. При этом наблюдается значительно меньшая частота развития побочных эффекModern therapeutic modes of treatment of autoimmune hepatitis
by: V. T. Ivashkin, et al.
Published: (2009-08-01)

PHARMACOLOGICAL STUDY OF NEPHROPROTECTIVE ACTION OF LIPOSOMAL ESSENTIAL PHOSPHOLIPIDS ON THE MODEL OF ENDOTHELIAL DYSFUNCTION IN PREGNANT RATS
by: O. V. Kudina
Published: (2014-09-01)

Hepatotoxicity of New Oral Anticoagulants
by: A. R. Kasimova, et al.
Published: (2018-09-01)

Transarterial intervention therapy plus systemic therapy for unresectable hepatocellular carcinoma: A systematic review and meta-analysis
by: Zelong Liu, et al.
Published: (2025-09-01)

Role of сathepsin G in pathogenesis of chronic obstructive lung disease: possible ways of regulation
by: V. A. Beloglazov, et al.
Published: (2020-05-01)

New possibilities for the treatment of glucocorticoid-induced osteoporosis
by: I.A. Baranova
Published: (2014-05-01)

On the safety of acetaminophen
by: R. N. Alyautdin, et al.
Published: (2022-06-01)

Drug-Induced Sarcoid-like Reactions Associated to Targeted Therapies and Biologic Agents
by: Federica Andolfi, et al.
Published: (2025-06-01)

Effectiveness assessment of sulfur-containing amino acids in rats with experimental “alcohol withdrawal syndrome” with modified zoosocial interaction methods
by: V. I. Petrov, et al.
Published: (2024-05-01)

COMPARATIVE ANALYSIS OF DRUG EFFICACY IN THE TREATMENT FOR COVID-19 SEVERE FORMS, BASED ON ATTRIBUTE-BASED STATISTIC METHODS AND ANALYSIS OF DRUG INTERACTIONS
by: O. V. Zhukova, et al.
Published: (2021-03-01)